BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26

• Press Releases

  Marengo Therapeutics Presents Phase 2 STARt-001 Results at ESMO 2026 Demonstrating Tissue-Agnostic Single-Agent Activity of Invikafusp Alfa in TMB-H Solid Tumors Mostly Unresponsive to Immune Checkpoint Blockade

  October 23, 2026

   · 

  8 min read
• Press Releases

  TORL BioTherapeutics Presents Preliminary Safety and Efficacy Data of Ixotatug Vedotin Monotherapy in Treatment-Refractory Germ Cell Tumors at the ESMO Congress 2026

  October 23, 2026

   · 

  6 min read
• Press Releases

  Precisio Biotix Therapeutics Receives Additional Funding to Advance a New Approach to Bacterial Vaginosis (BV), A Major Women’s Health Issue

  October 23, 2026

   · 

  3 min read
• Press Releases

  Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study

  October 23, 2026

   · 

  14 min read
• Press Releases

  Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breast01 Study

  October 23, 2026

   · 

  7 min read
• Press Releases

  ImPact Biotech Reports Encouraging Early Clinical Results From Phase 1 Study of Padeliporfin VTP in Pancreatic Cancer, with Seven Previously Unresectable Patients Undergoing Surgical Resection Following Treatment

  October 23, 2026

   · 

  4 min read
• Press Releases

  Avacta Highlights pre|CISION® Platform Data and Ongoing FOCUS-01 Trial Design with FAP-Exd (AVA6103)

  October 23, 2026

   · 

  7 min read
• Press Releases

  Humacyte at ASN Kidney Week: Phase 3 Trial Built for Women Shows ATEV Advantage Over Fistula, Getting Patients Off Catheters Months Sooner

  October 23, 2026

   · 

  10 min read
• Press Releases

  Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026

  October 23, 2026

   · 

  6 min read
• Press Releases

  Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026

  October 23, 2026

   · 

  8 min read